title: [Targeting mTOR and identification of « exceptional responders »].
authors.affiliation: Institut Bergonié, 229, cours de l'Argonne, 33076 Bordeaux cedex.
authors.forename: Jacques
authors.initials: J
authors.lastname: Robert
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D000068338:Everolimus / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage*; D013449:Sulfonamides / Q000008:administration & dosage*; D058570:TOR Serine-Threonine Kinases / Q000235:genetics*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines; D013449:Sulfonamides; D000068338:Everolimus; D058570:TOR Serine-Threonine Kinases